Idorsia (IDRSF) News Today $1.00 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Idorsia issues invitation to the 2025 Annual General Meeting of ShareholdersMay 2 at 1:00 AM | globenewswire.comHigher cantonal composition authority approved the amendments to the terms of the 2025 convertible bondApril 16, 2025 | finance.yahoo.comIdorsia Pharmaceuticals Ltd: Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bondApril 16, 2025 | finanznachrichten.deIdorsia Pharmaceuticals Ltd: US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirementApril 9, 2025 | finanznachrichten.deUS FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirementApril 9, 2025 | finance.yahoo.comIdorsia Pharmaceuticals Ltd: Idorsia publishes its Annual Report 2024March 27, 2025 | finanznachrichten.deIdorsia publishes its Annual Report 2024March 27, 2025 | globenewswire.comIdorsia Ltd (IDIA) Receives a Hold from Kepler CapitalMarch 19, 2025 | markets.businessinsider.comUS FDA removes REMS requirement for TRYVIO (aprocitentan) – minimizing the burden on the healthcare delivery systems and patientsMarch 17, 2025 | uk.finance.yahoo.comIdorsia Pharmaceuticals Ltd: Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturiaMarch 15, 2025 | finanznachrichten.deIdorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturiaMarch 14, 2025 | globenewswire.comIdorsia Ltd (IDRSF) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comIdorsia Ltd (IDRSF) (Q4 2024) Earnings Call Highlights: Strategic Moves and Financial ResilienceMarch 5, 2025 | gurufocus.comFull Year 2024 Idorsia Ltd Earnings Call TranscriptMarch 5, 2025 | gurufocus.comIdorsia announces financial results for 2024March 4, 2025 | globenewswire.comKepler Capital Remains a Hold on Idorsia Ltd (IDIA)February 27, 2025 | markets.businessinsider.comInvitation to Idorsia's Full Year 2024 Financial Reporting webcast and conference callFebruary 27, 2025 | globenewswire.comBondholders approve amended terms of the 2025 convertible bondsFebruary 26, 2025 | uk.finance.yahoo.comIdorsia’s Tryvio deal collapses, forcing company to find cash urgentlyFebruary 26, 2025 | finance.yahoo.comIdorsia is released from exclusivity constraint regarding the global rights to aprocitentan – now pivoting to alternative partiesFebruary 26, 2025 | globenewswire.comIdorsia and Viatris update their collaboration for selatogrel and cenerimodFebruary 26, 2025 | globenewswire.comIdorsia reaches an agreement with significant bondholders to restructure its convertible bond debt and to secure funding for future operationsFebruary 26, 2025 | globenewswire.comKepler Capital Sticks to Their Hold Rating for Idorsia Ltd (IDIA)February 13, 2025 | markets.businessinsider.comIdorsia Pharmaceuticals Ltd: Idorsia publishes the resolutions for the upcoming bondholder meetingFebruary 12, 2025 | finanznachrichten.deIdorsia publishes the resolutions for the upcoming bondholder meetingFebruary 12, 2025 | globenewswire.comInsiders own 26% of Idorsia Ltd (VTX:IDIA) shares but individual investors control 59% of the companyJanuary 26, 2025 | uk.finance.yahoo.comIdorsia Pharmaceuticals Ltd: Idorsia presents at J.P. Morgan Healthcare Conference 2025 - fighting to create value for all stakeholdersJanuary 16, 2025 | finanznachrichten.deSanthera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by IdorsiaJanuary 16, 2025 | markets.businessinsider.comIdorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholdersJanuary 15, 2025 | globenewswire.comKepler Capital Keeps Their Hold Rating on Idorsia Ltd (IDIA)January 15, 2025 | markets.businessinsider.comIdorsia publishes an invitation to a bondholder meetingJanuary 14, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Idorsia to call for a bondholder meetingJanuary 13, 2025 | finanznachrichten.deIdorsia Shares Plunge After Proposing Changes to Bonds TermsJanuary 13, 2025 | marketwatch.comIdorsia to call for a bondholder meetingJanuary 13, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Idorsia provides update on the exclusive negotiations for the global rights to aprocitentanDecember 20, 2024 | finanznachrichten.deIdorsia Shares Plunge After Hypertension Drug Deal StallsDecember 20, 2024 | marketwatch.comIdorsia provides update on the exclusive negotiations for the global rights to aprocitentanDecember 20, 2024 | globenewswire.comIdorsia, with U.S. operations on the Main Line, expects to cut hundreds of jobsNovember 29, 2024 | bizjournals.comSwiss pharma firm Idorsia plans debt restructuring, job cutsNovember 27, 2024 | reuters.comIdorsia enters into exclusive negotiations for global rights to aprocitentanNovember 27, 2024 | globenewswire.comIdorsia's once-daily TRYVIO™ (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertensionNovember 15, 2024 | prnewswire.comIdorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific SessionsNovember 11, 2024 | globenewswire.comOne Idorsia Ltd (VTX:IDIA) Analyst Just Slashed Their Estimates By A Considerable 33%November 6, 2024 | finance.yahoo.comIdorsia upgraded to Hold from Sell at Deutsche BankNovember 5, 2024 | markets.businessinsider.comIdorsia rating suspended at Goldman SachsOctober 30, 2024 | markets.businessinsider.comIdorsia price target lowered to CHF 1.20 from CHF 2 at JPMorganOctober 22, 2024 | markets.businessinsider.comSome Analysts Just Cut Their Idorsia Ltd (VTX:IDIA) EstimatesOctober 20, 2024 | finance.yahoo.comIdorsia continues to further the science of sleep and insomnia with new daridorexant data and analyses published at Sleep Europe 2024September 17, 2024 | globenewswire.comAmended terms of Idorsia’s 2024 convertible bonds become effectiveSeptember 2, 2024 | uk.finance.yahoo.comIdorsia Pharmaceuticals Ltd: Amended terms of Idorsia's 2024 convertible bonds become effectiveSeptember 2, 2024 | finanznachrichten.de Get Idorsia News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRSF and its competitors with MarketBeat's FREE daily newsletter. Email Address IDRSF Media Mentions By Week IDRSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRSF News Sentiment▼0.000.73▲Average Medical News Sentiment IDRSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRSF Articles This Week▼11▲IDRSF Articles Average Week Get Idorsia News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IDRSF) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idorsia Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Idorsia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDRSF Stock Free IDRSF Stock Alerts